Myriad Genetics director granted 59,701 RSUs
Dreismann Heinrich reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Dreismann Heinrich reported acquisition or exercise transactions in this Form 4 filing.
MYRIAD GENETICS INC director Heinrich Dreismann received a grant of 59,701 restricted stock units of common stock. The award was made at no cash cost per share and is part of the company’s 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a right to receive one common share and will vest upon the earlier of the first anniversary of the grant date or the next annual stockholder meeting. Following this equity award, Dreismann directly holds 231,145 shares of Myriad Genetics common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 59,701 | $0.00 | $0.00 |
Footnotes (1)
- F1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.
Key Figures
Key Terms
restricted stock units financial
Equity Incentive Plan financial
vests financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MYRIAD GENETICS (MYGN) report for Heinrich Dreismann?
When do Heinrich Dreismann’s MYGN restricted stock units vest?
Was the MYGN equity grant to Heinrich Dreismann an open-market purchase or compensation award?
AI-generated analysis. How Rhea-AI works. Not financial advice.